|Day Low/High||64.84 / 65.92|
|52 Wk Low/High||41.62 / 68.64|
Let's see what the charts look like the day after the State of the Union address.
These are the 10 reasons why we keep going up, despite all the bad news.
The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.
It is early in the game but here's what traders can do.
A little bit of luck and a lot of homework can go a long way to make Big Money out of Mad Money. It's buying a Biogen, a Centene, or a Bristol-Myers that could do just that for you.
There is a chance that Presidents Trump and Xi sign something when they meet up at the APEC summit this November in Santiago, Chile.
Downside momentum has been slowing in the healthcare company's shares, which could foreshadow a low or a reversal.
Also, defense industry names can breathe easier with word of debt ceiling and federal spending deal.
A rally above the highs of April and May or above $58 will be positive for the provider of healthcare programs.
A look at the charts and indicators of three big names in the sector .
These managed care stocks can withstand China, politics and a slowdown in the economy.
Netflix led the charge in FANG names. And why MRCY is now a hot stock in the defense sector.
The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.
It becomes difficult to own for anything other than a trade, managed care stocks and those that most benefit from Medicare expansion.
With the stock split a fresh look at the split adjusted stock is now in order.
Dow Theory presents tips for surviving a bear market, some top year-end stock bargains and a simple strategy for monthly income.
Shares of the healthcare company are showing unhealthy tendencies right now after a federal judge rules Obamacare unconstitutional.
Use it to your advantage or don't use it at all.
Centene prices have been in a neutral or sideways trading range since the middle of August.
Straying from these names could land you in quicksand as the 4th quarter begins.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
It is all about perception, and here are strong names to pick up on market weakness.
Here are some options strategies for this FANG name into tomorrow's report.
Our GLUM Index stocks will be hit hard by this trade war.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Monday's trending market topics from the floor of the New York Stock Exchange.